Updated:
NantHealth
NantHealth builds technology to simplify healthcare for payers and providers.
NantHealth
NantHealth develops technology that streamlines communication between health insurers and healthcare providers. The company was founded by Dr. Patrick Soon-Shiong, a surgeon and entrepreneur whose previous ventures include Abraxis BioScience and the ownership of the Los Angeles Times. NantHealth operates across North America and Europe, with offices in New York, Dallas, El Segundo, Philadelphia, Waterloo (Canada), London, and Belfast. The firm's product suite includes NaviNet, a multi-payer portal for administrative and clinical data exchange; Eviti Connect, an evidence-based decision-support platform for oncology and autoimmune disease treatment; and OpenNMS, an open-source network monitoring solution. NantHealth claims a 6:1 ROI for customers using Eviti Connect and over 1,200 accessible health plans through NaviNet AllPayer. The company targets payers and providers seeking to reduce manual processes and contain costs through automation. NantHealth is a subsidiary of NantWorks, the umbrella organization for Dr. Soon-Shiong's healthcare and technology ventures. The firm reported enabling $30,000 in savings per 10,000 transactions via its NaviNet platform. In 2024, NantHealth continued to support the launch of NantIQ, an AI-driven patient empowerment initiative (per the firm's website, 2024). A structural differentiator is NantHealth's integration with NantWorks' broader ecosystem, which includes genomics, AI, and drug development capabilities. This allows the company to offer a vertically connected suite of data and decision tools spanning from molecular diagnostics to provider reimbursement, aligning value-based care goals across the care continuum.
General information
Firm type
other
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
New York
Corporate office
New York, NY, United States
Additional offices
Waterloo, Canada · Chicago, IL, United States · El Segundo, CA, United States · London, United Kingdom · Dallas, TX, United States · Philadelphia, PA, United States · Belfast, Northern Ireland, United Kingdom
Sector focus
Frequently asked questions
Who controls investment decisions at NantHealth?
NantHealth is a subsidiary of NantWorks, founded by Dr. Patrick Soon-Shiong. The company's board of directors includes senior executives from NantWorks and independent members. Day-to-day operational leadership is managed by a corporate executive team, though specific investment decisions for the technology platforms are not publicly detailed.
Is NantHealth a family office or an operating company?
NantHealth is a healthcare technology operating company, not a family office. It develops and sells software platforms (NaviNet, Eviti Connect, OpenNMS) to payers and providers. It is part of the broader NantWorks ecosystem, which functions as a holding company for diverse ventures controlled by Dr. Soon-Shiong.
What investment stages does NantHealth target?
NantHealth does not invest in external companies. It focuses on building internal technology products for the healthcare market. The firm's platforms serve payers and providers at the operational level, with products like Eviti Connect targeting clinical decision support and NaviNet automating administrative workflows.
Which sectors does NantHealth explicitly avoid?
NantHealth concentrates exclusively on healthcare technology and does not engage in financial services, real estate, or traditional asset management. There is no public disclosure of any explicit avoidance list, but the firm's stated focus is payer-provider collaboration and value-based care.
How is NantHealth related to NantWorks?
NantHealth is a direct subsidiary of NantWorks, the holding company established by Dr. Patrick Soon-Shiong. NantWorks also includes NantKwest (cell therapy), NantOmics (genomics), and other entities. NantHealth's technology platforms are designed to integrate with other NantWorks verticals, such as precision medicine and diagnostic data.
Does NantHealth participate in fund commitments or only direct deals?
NantHealth does not publicly report any fund commitments. It is a product-focused operating company, not an investment firm. It does not make direct equity investments or engage in venture capital activities separate from its internal R&D and commercial partnerships.
Where does the underlying wealth come from?
The wealth originates from Dr. Patrick Soon-Shiong, who built his fortune through pharmaceutical ventures, including the development of the cancer drug Abraxane and the sale of Abraxis BioScience. He also owns the Los Angeles Times. NantHealth is one operating subsidiary within his broader healthcare conglomerate.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: